These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33135337)

  • 1. Progress and applications of mass cytometry in sketching immune landscapes.
    Zhang T; Warden AR; Li Y; Ding X
    Clin Transl Med; 2020 Oct; 10(6):e206. PubMed ID: 33135337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass cytometry: a highly multiplexed single-cell technology for advancing drug development.
    Atkuri KR; Stevens JC; Neubert H
    Drug Metab Dispos; 2015 Feb; 43(2):227-33. PubMed ID: 25349123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials.
    Gadalla R; Noamani B; MacLeod BL; Dickson RJ; Guo M; Xu W; Lukhele S; Elsaesser HJ; Razak ARA; Hirano N; McGaha TL; Wang B; Butler M; Guidos CJ; Ohashi PS; Siu LL; Brooks DG
    Front Oncol; 2019; 9():415. PubMed ID: 31165047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CyTOF: An Emerging Technology for Single-Cell Proteomics in the Mouse.
    Tracey LJ; An Y; Justice MJ
    Curr Protoc; 2021 Apr; 1(4):e118. PubMed ID: 33887117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Clinical Mass Cytometry.
    Koladiya A; Davis KL
    Clin Lab Med; 2023 Sep; 43(3):507-519. PubMed ID: 37481326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow Cytometry and Mass Cytometry for Measuring the Immune Cell Infiltrate in Atherosclerotic Arteries.
    Orecchioni M; Meyer MA; Hedrick CC; Ley K
    Methods Mol Biol; 2022; 2419():779-800. PubMed ID: 35238001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep Profiling of the Immune System of Multiple Myeloma Patients Using Cytometry by Time-of-Flight (CyTOF).
    Smets T; Stevenaert F; Adams HC; Vanhoof G
    Methods Mol Biol; 2018; 1792():47-54. PubMed ID: 29797251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reagents for Mass Cytometry.
    Arnett LP; Rana R; Chung WW; Li X; Abtahi M; Majonis D; Bassan J; Nitz M; Winnik MA
    Chem Rev; 2023 Feb; 123(3):1166-1205. PubMed ID: 36696538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Cell Profiling of the Intrinsic Apoptotic Pathway by Mass Cytometry (CyTOF).
    Tan T; Gray DHD; Teh CE
    Methods Mol Biol; 2022; 2543():83-97. PubMed ID: 36087261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of Mass Cytometry in Clinical Medicine: The Promise and Perils of Clinical CyTOF.
    Behbehani GK
    Clin Lab Med; 2017 Dec; 37(4):945-964. PubMed ID: 29128078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Streamlined CyTOF Workflow To Facilitate Standardized Multi-Site Immune Profiling of COVID-19 Patients.
    Geanon D; Lee B; Kelly G; Handler D; Upadhyaya B; Leech J; Herbinet M; Del Valle D; Gnjatic S; Kim-Schulze S; Merad M; Rahman A
    medRxiv; 2020 Jun; ():. PubMed ID: 32607524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CyTOF Mass Cytometry for Click Proliferation Assays.
    Tosevski V; Ulashchik E; Trovato A; Cappella P
    Curr Protoc Cytom; 2017 Jul; 81():7.50.1-7.50.14. PubMed ID: 28678421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T-Cell Phenotyping Using CyTOF.
    Barcenilla H; Pihl M; Sjögren F; Magnusson L; Casas R
    Methods Mol Biol; 2023; 2559():231-242. PubMed ID: 36180636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline immune profile by CyTOF can predict response to an investigational adjuvanted vaccine in elderly adults.
    Lingblom CMD; Kowli S; Swaminathan N; Maecker HT; Lambert SL
    J Transl Med; 2018 Jun; 16(1):153. PubMed ID: 29866115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated cell type annotation and exploration of single-cell signaling dynamics using mass cytometry.
    Kleftogiannnis D; Gavasso S; Tislevoll BS; van der Meer N; Motzfeldt IKF; Hellesøy M; Gullaksen SE; Griessinger E; Fagerholt O; Lenartova A; Fløisand Y; Schuringa JJ; Gjertsen BT; Jonassen I
    iScience; 2024 Jul; 27(7):110261. PubMed ID: 39021803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass cytometry to characterize the immune lung cancer microenvironment.
    Badri T; Eguren-Santamaria I; Fernandez-Pierola E; Sanmamed MF
    Methods Cell Biol; 2023; 174():31-41. PubMed ID: 36710049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Techniques Made Simple: Experimental Methodology for Single-Cell Mass Cytometry.
    Matos TR; Liu H; Ritz J
    J Invest Dermatol; 2017 Apr; 137(4):e31-e38. PubMed ID: 28340685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CD45-based barcoding approach to multiplex mass-cytometry (CyTOF).
    Lai L; Ong R; Li J; Albani S
    Cytometry A; 2015 Apr; 87(4):369-74. PubMed ID: 25645694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass cytometry for the multiplexed quantification and characterization of target expression on circulating cells in whole blood.
    Stevens CR; Atkuri K; Menard DL; King LE; Neubert H; Goihberg P
    Cytometry A; 2023 Aug; 103(8):631-645. PubMed ID: 36966446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward High-Dimensional Single-Cell Analysis of Graphene Oxide Biological Impact: Tracking on Immune Cells by Single-Cell Mass Cytometry.
    Orecchioni M; Bordoni V; Fuoco C; Reina G; Lin H; Zoccheddu M; Yilmazer A; Zavan B; Cesareni G; Bedognetti D; Bianco A; Delogu LG
    Small; 2020 May; 16(21):e2000123. PubMed ID: 32338440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.